Research summary, original research, 2026

Eye lens dose in interventional cardiology personnel in Vietnam: direct Hp(3) measurement, indirect method comparison, and fluoroscopy-time-based dose estimation

Nguyen NTT, Pham TN, Tran NY, Ta HA, Dang LT, Ho DM. Radiation protection dosimetry. 2026

Read the original paper

In plain language

In 12 cath lab staff in Vietnam, projected annual eye lens doses for physicians reached up to 19.10 mSv, near the 20 mSv limit, and five physicians exceeded a 6 mSv investigation level. An indirect two-dosemeter method overestimated dose.

At a glance

Type of study
Original research, Dosimetry measurement study
Who was studied
Interventional cardiologists, Radiologic technologists
Size
n = 12 personnel
Where
Vietnam
Summary based on
the abstract

What it found

  • Annualized eye lens dose projections for physicians approached the International Commission on Radiological Protection (ICRP) 20 mSv/year limit.

    Key figures: up to 19.10 mSv/year

  • Five of eight physicians exceeded the IRPA investigation level for eye lens dose.

    Key figures: 5 physicians > 6 mSv/year

  • Direct Hp(3) over the monitoring period (extrapolated to 12 weeks) was higher in physicians than in technicians.

    Key figures: 0.58-4.59 mSv (physicians); 0.26-1.01 mSv (technicians)

  • The SSRPM two-dosemeter indirect method overestimated direct eye lens measurements.

    Key figures: mean factors of 1.31 (physicians) and 1.68 (technicians)

  • Physician eye lens dose correlated strongly with fluoroscopy time.

    Key figures: R2 = 0.918

Limits to keep in mind

Small sample (12 personnel, one Siemens Artis Zee system) monitored for 10 weeks, with extrapolation to 12 weeks and annual projections; abstract only, with no detail on eye protection use during monitoring.

How this summary was made

ORSIF prepared this summary with AI assistance from the abstract of the paper. A program then checked that the passage supporting each finding appears word for word in that source. A person has not yet reviewed each summary, so read the original before relying on a number. ORSIF summarizes research and does not endorse any product or company. Report a problem with this summary.

Prepared November 3, 2026.